NeoGenomics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
66,467.00
87,069.00
99,802.00
244,083.00
258,611.00
276,741
Cost of Goods Sold (COGS) incl. D&A
34,953.00
48,479.00
58,950.00
137,904.00
144,591.00
163,004
Gross Income
31,514.00
38,590.00
40,852.00
106,179.00
114,020.00
113,737
SG&A Expense
28,340.00
36,011.00
41,787.00
100,141.00
110,638.00
101,397
EBIT
3,174.00
2,579.00
-
-
3,382.00
12,340
Unusual Expense
-
361.00
4,700.00
3,464.00
-
2,300
Non Operating Income/Expense
-
-
2,000.00
-
1,323.00
14
Interest Expense
989.00
929.00
854.00
9,998.00
5,540.00
6,230
Pretax Income
2,185.00
1,289.00
4,489.00
7,424.00
3,481.00
3,824
Income Tax
152.00
157.00
1,954.00
1,701.00
2,635.00
1,184
Consolidated Net Income
2,033.00
1,132.00
2,535.00
5,723.00
846.00
2,640
Net Income
2,033.00
1,132.00
2,535.00
5,723.00
846.00
2,640
Net Income After Extraordinaries
2,033.00
1,132.00
2,535.00
5,723.00
846.00
2,640
Net Income Available to Common
2,033.00
1,132.00
2,657.00
30,397.00
11,393.00
6,088
EPS (Basic)
0.04
0.02
0.04
0.39
0.14
0.07
Basic Shares Outstanding
48,263.00
53,483.00
60,526.00
77,542.00
79,426.00
85,618
EPS (Diluted)
0.04
0.02
0.04
0.39
0.14
0.07
Diluted Shares Outstanding
52,775.00
56,016.00
60,526.00
77,542.00
79,426.00
91,568
EBITDA
7,586.00
8,219.00
6,207.00
29,247.00
25,973.00
34,072
Preferred Dividends
-
-
122.00
24,674.00
10,547.00
3,448
About NeoGenomics
View Profile
